openPR Logo
Press release

Fibromyalgia Therapeutics Market with Result, Challenges, Research, Froecast Growth 2019, Global Demand

10-05-2017 01:32 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Fibromyalgia Therapeutics Market with Result, Challenges,

Fibromyalgia is a disorder characterized by muscle pain, fatigue and allodynia. Although the disease mostly affects females, rarely males and children may also be affected. Individuals suffering from fibromyalgia develop tender points on their body especially neck, back, hip and legs. On applying pressure, patients feel intense pain at these tender point. Symptoms of fibromyalgia include insomnia, morning stiffness, headache, painful menstrual periods, and numbness in hand and figures. Fibromyalgia is of three types namely Hyperalgesia, Allodynia and Paresthesia. Hyperalgesia is increased sensitivity to pain which may arise due to damage of peripheral nerves. Allodynia is characterized by heightened painful feeling to pressure on certain points on body. Paresthesiais sensation of tingling, prickling, or burning on skin. Although there is no cure for fibromyalgia the treatment is provided for easing the symptoms of the disorder. The market for

Get Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1861

fibromyalgia therapeutics can be segmented as below:

Segmentation based on brand
Cymbalta (duloxetine)
Savella (milnacipran)
Lyrica (pregabalin)
Although a number of off label drugs such as antidepressants, painkillers, and muscle relaxant are prescribed for relieving from the symptoms, FDA approved drugs include Cymbalta, Savella, and Lyrica. Cymbalta is manufactured by Eli Lilly and Co. The drug accounted for about 22% of the company’s sales in 2012. The patent for the drug has been expired in 2013 and is available for manufacture of generic version. Savella is manufactured by Forest Pharmaceuticals, Inc. and its patent expires in 2021. Lyrica is manufactured by Pfizer and the exclusivity period has been recently extended till 2018. The drug had generated USD 3.7 billion sales in 2011.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

View TOC for this Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1861

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fibromyalgia Therapeutics Market with Result, Challenges, Research, Froecast Growth 2019, Global Demand here

News-ID: 757712 • Views:

More Releases from Transparency Market Research

Europe Insect Screen Market Poised for Steady Growth on the Back of Rising Health Awareness and Energy-Efficient Living Trends | TMR
Europe Insect Screen Market Poised for Steady Growth on the Back of Rising Healt …
The Europe Insect Screen Market continues to gain momentum, driven by heightened emphasis on public health, energy efficiency, and sustainable building solutions. Valued at US$ 285.4 Mn in 2024, the market is set to grow consistently and reach US$ 480.0 Mn by 2035, expanding at a CAGR of 5.0% during the forecast period. Increasing focus on maintaining hygienic indoor environments, coupled with advancements in building technologies, is accelerating the adoption of
Tennis Ball Machines Market to Reach USD 40.3 Million by 2035, Driven by Rising Tennis Participation and Smart Training Technologies
Tennis Ball Machines Market to Reach USD 40.3 Million by 2035, Driven by Rising …
According to a new research report published by Transparency Market Research, the global tennis ball machines market was valued at US$ 27.4 Mn in 2024 and is projected to reach US$ 40.3 Mn by 2035, expanding at a CAGR of 3.4% from 2025 to 2035. The market is witnessing steady expansion driven by a surge in tennis participation, rising adoption of advanced training tools, and strong consumer preference for lightweight,
Global Poultry Farming Equipment Market to Reach USD 6.7 Bn by 2034, Driven by Automation, Sustainability, and Rising Demand for Poultry Protein
Global Poultry Farming Equipment Market to Reach USD 6.7 Bn by 2034, Driven by A …
The global poultry industry is entering a new era of modernization as farms worldwide adopt advanced, automated equipment to meet soaring demand for poultry products. According to the latest market assessment, the global poultry farming equipment market was valued at US$ 4.1 Bn in 2023 and is projected to expand steadily at a CAGR of 4.5% from 2024 to 2034, reaching US$ 6.7 Bn by 2034. This growth is fueled
Europe External Blinds Market Set to Reach USD 22.9 Billion by 2034, Driven by Smart Home Integration and Energy-Efficient Building Trends
Europe External Blinds Market Set to Reach USD 22.9 Billion by 2034, Driven by S …
The Europe External Blinds Market is positioned for steady growth over the next decade, with market value expected to rise from US$ 15.2 billion in 2023 to US$ 22.9 billion by 2034, expanding at a CAGR of 3.9% from 2024 to 2034. Increasing adoption of smart home solutions, rising environmental consciousness, and strong government regulations supporting energy efficiency are key factors contributing to this growth. Introduction: External blinds have emerged as

All 5 Releases


More Releases for Fibromyalgia

Government Initiatives On Musculoskeletal Health Propel Growth In The Fibromyalg …
The Fibromyalgia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Fibromyalgia Treatment Market? The market for the treatment of fibromyalgia has been expanding consistently in past years. At a compound annual growth rate (CAGR) of 3.9%, it is
SN Clinic's Effective Treatment of Fibromyalgia Symptoms
Image: https://www.globalnewslines.com/uploads/2025/02/1740408683.jpg SN Clinic Logo Fibromyalgia can be a debilitating condition, but SN Clinic offers hope through innovative treatments like MLS Laser Therapy and complementary massage therapies. By addressing chronic pain through a holistic approach, patients can experience significant relief and an improved quality of life. What is Fibromyalgia and What Does Current Data Say? Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. Affecting
Prominent Fibromyalgia Treatment Market Trend for 2025: Market Leaders Focus On …
What Are the Projected Growth and Market Size Trends for the Fibromyalgia Treatment Market? The Fibromyalgia Treatment market is expected to grow from $2.79 billion in 2024 to $2.9 billion in 2025, at a CAGR of 3.9%. This growth is attributed to the increasing prevalence of fibromyalgia, greater awareness about the condition, government initiatives, and rising disposable incomes. The fibromyalgia treatment market is projected to see steady growth, reaching $3.45 billion by
Advancements in Fibromyalgia Treatments Driving Market Expansion
The fibromyalgia treatment market is experiencing a steady upward trajectory, with significant growth expected over the next decade. Estimated at USD 2.77 billion in 2023, the market is projected to reach approximately USD 4.13 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2032. This expansion is driven by several key factors, including advances in treatment options, increasing demand for effective therapies, and
Fibromyalgia - Drug Pipeline Landscape, 2022
Fibromyalgia is a is a common chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep, memory and cognitive issues. Researchers reported that repeated nerve stimulation causes the brain and spinal cord of people with fibromyalgia to change. The conditions conditions that may bring on symptoms, such as: stressors, viral infections or other illnesses like arthritis, anxiety, depression, other mood disorders, PTSD. To know more about Fibromyalgia - Drug Pipeline, visit - https://www.globalinsightservices.com/reports/fibromyalgia-drug-pipeline-landscape-2022/ Fibromyalgia
Fibromyalgia Treatment Market 2022 | Increased Morbidity of Fibromyalgia Along w …
According to Precision Business Insights (PBI), the latest report, the Fibromyalgia Treatment market is expected to be valued at USD 3,017.9 million in 2022, growing at an 3.8% CAGR from 2022 to 2028. Fibromyalgia treatment market analysis projects that the increased prevalence of fibromyalgia and its related complication compelled the introduction of targeted & precise treatment methods for fibromyalgia. Also, the increase in awareness about fibromyalgia will give the required